ArticleCurrent medical imaging2026
Comparative Analysis of Clinical and MR Imaging Characteristics between Dual-Phenotype Hepatocellular Carcinoma and Conventional Hepatocellular Carcinoma: A Retrospective Study
Article in Current medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to investigate the clinical and MR imaging differences between dual-phenotype hepatocellular carcinoma (DPHCC) and conventional hepatocellular carcinoma (HCC).
methodsA retrospective analysis was conducted on the clinical data and MRI findings of 29 patients with DPHCC and 29 propensity score-matched patients with conventional HCC, confirmed by surgical pathology, from January 2019 to January 2022 at Fudan University Zhongshan Hospital. Clinical characteristics, lesion location, morphology, size, signal intensity, enhancement patterns, vascular invasion, and lymph node metastasis were analyzed for both groups.
resultsBetween the DPHCC group and the HCC group, statistically significant differences were found in cirrhosis, pathological grade, lesion morphology, enhancement patterns, delayed capsular enhancement, and lymph node metastasis. There were no statistically significant differences between the two groups in terms of age, gender, hepatitis B infection, AFP, CA199, microvascular invasion (MVI), capsular invasion, lesion size, location, vascular invasion, ADC values, and T1WI and T2WI signals.
conclusionCompared to HCC, DPHCC has a higher pathological grade, more irregular lesion morphology, and a higher incidence of both fast-in and slow-out and slow-in and slow-out enhancement patterns, as well as higher rates of lymph node metastasis. The findings have provided valuable insights for the accurate diagnosis of DPHCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.